Movement Alert|Zoetis Rises 5.07% in Regular Trading, Trading at $81.48

Market Focus06-04

On June 4, Zoetis rose 5.07% in regular trading, trading at $81.48/share, with trading volume of $173 million.

Within the Pharmacy sector where Zoetis belongs, the overall sector performed strongly. Among individual stocks, Novo-Nordisk up 5.25%, Eli Lilly up 5.01%, Merck up 3.48%, Johnson & Johnson up 1.79%, Pfizer up 1.76%.

Zoetis Inc. is a global leader in animal health, focused on the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products, and services across livestock and companion animal species.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment